Pill-Sized Robot Tests Tumours In Body
Scientists have developed a pill-sized robot that can travel inside your body, can find if you have any tumours
and transmit the findings back to a computer//.
After being swallowed, the robot passes through the body naturally, reported the online edition of Daily Mail. The miniature video ca...
A Protein That Increases Risk Of Tumours
A protein that protects the body from tissue damage also increases the risk of tumours, says a study.
Researchers at Washington University School of Medicine in St. Louis tested the protein Bcl-xL that helps the body's healthy cells // survive the effects of toxic chemotherapeutic agents.
Lancing tumours into the body
A team of micromachine experts report this week that they have developed tiny spinning screws that could swim along veins, ferrying drugs to infected tissues, or even burrow into tumours
to kill them off with a hot lance.Kazushi Ishiyama at Tohoku University in Japan has designed swimming micromach...
Electric Field Therapy to Zap Cancerous Tumours
Boffins have made a new device, Novo-TTF (Tumor-Treating Fields), for treating brain cancer patients using electrical field therapy, which could more than double the survival rates for people with one of the most common types of brain tumour.
The device uses low intensity electrical fields...
Stem Cells from Human Fat Tissue to Hunt for and Kill Cancerous Tumours
Boffins have developed a new gene therapy by using 'suicide genes' derived from mesenchymal stem cells taken from human fat tissue, which hunt for and kill cancerous tumours.
The study was conducted by a team of researchers led by Cestmir Altaner at the Cancer Research Institute of the Slo...
Radio-frequency Ablation Offers Hope for People With Inoperable Kidney Tumours
People with inoperable kidney and liver tumours
may rely on a new, non-surgical procedure called Radio-frequency ablation (RFA), which has already been successful in treating Hollywood talent manager , Louis Bershad, after he was diagnosed with a malignant tumour in his left kidney.
Nanoparticles Used by Researchers to Attack Brain Tumours
Treating brain tumors is traditionally difficult because of the blood-brain barrier, which prevents harmful substances from traveling //through the bloodstream into the brain. In order for chemotherapy to treat a tumor, it must penetrate this barrier.
'Thinking outside the box is a must for d...
Awake Surgery to treat Brain tumours
The need for more awake surgery was made at a major conference on brain tumours
in Dublin organised by the Irish Cancer Society. //
According to the Irish Cancer Society, in spite of the awake surgery being time-consuming and expensive, it has higher rate of success and any damge to the ...
Alcohol Drinking Affects Risk Of Colorectal Tumours
Drinking beer and alcohol increases the risk of colorectal tumours, while drinking wine in moderation lowers the risk, according to a study. //
The study, conducted by Joseph C. Anderson, M.D. and colleagues at Stony Brook University, Stony Brook, New York, was meant to examine the impact of r...
Alcohol Consumption A Threat To Colorectal Tumours
Alcohol is considered not good for health as it induces lot of alterations in the metabolism of the body. Drinking beer and alcohol increases the risk of colorectal tumours, while drinking in moderation lowers the risk, according to a study. //
The study was conducted by Joseph C. Anderson, ...
Tumours in Medical Technology
Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
CALGARY, March 12 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ) announced today that it has started patient enrolment in a Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients w...
Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer
...al trials, and ultimately, for treatment with PLX4032.
"PLX4032 has shown both tumour shrinkage and delay in tumour progression in patients whose tumours
harbour a BRAF mutation, as well as improved quality of life for symptomatic patients," stated Keith T. Flaherty, M.D., assistant professor at the Abr...
Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
...ts suffer a relapse within two years and recurrent tumours
often more aggressive and more difficult to tr...nes for the management of
gastrointestinal stromal tumours
http://www.cancerimprovement.nhs.uk/%5Cd...atients with KIT
(CD117)-positive gastrointestinal tumours
(GIST), which cannot be surgically
removed and/or ...
Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
...ordisk based on the available data had ruled out that the finding of C-cell tumours
in rodents was not relevant to humans, the Advisory Committee was split on the FDA question related to whether the available data on C-cell tumours
Finally, the Advisory Committee unanimous...
BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
...ed data from its clinical
studies with its breast cancer vaccine, MVA-BN(R)-HER2, in development as
therapy of metastatic breast cancer patients whose tumours
The study met its primary endpoint with regards to safety and by showing an
immune response. Evidence of vaccine-induced anti-HER2 ...
ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
...t and ThromboGenics.
TB-403 (anti-PlGF) is a humanized monoclonal antibody that blocks the
formation of the new blood vessels required by solid tumours
growth. PlGF is a homologue of VEGF, and clinical evidence suggests that it
plays a role in the angiogenesis of malignant tissue, and does ...
Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora
... NERVIANO, Italy, October 23 /PRNewswire/ --
- First Responses in Solid tumours
Aurora inhibitors play a key role in cell duplication and are
i...ted Phase I studies and is
now undergoing clinical Phase II trials in solid tumours
and blood cancers
at some of the most widely acknowledged international cli...
Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
...olling cell fate specification could generate
innovative anti-cancer drugs with anti-tumoural, anti-metastatic and
anti-angiogenic properties to treat tumours
that are currently resistant to
standard therapies," said Kamel Besseghir, CEO of Debiopharm S.A.
About Debiopharm Group
Debiopharm Group is a glo...
AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
...in cancer cell growth. AstraZeneca is leading
the way in unlocking the potential of MEK inhibitors in the treatment of
cancer. Targeting MEK dependant tumours
offers an exciting opportunity to
develop a more personalised, targeted approach to the treatment of cancer.
This is a selective cytokines...
Cytopia Appoints Study Chairman for JAK2 Clinical Trial
...Cytopia is developing a suite of JAK2 inhibitors for multiple
indications including the treatment of certain cancers, particularly
lymphomas and solid tumours
where JAK2 has been shown to be upregulated,
and for cardiovascular diseases such as pulmonary hypertension.
Cytopia Ltd is an Austr...
Tumours in Medical Definition
... lymphoma in the pathology specimen .
^ Jaffe, ES, Harris, NL, Stein, H., and Vardiman, JW, eds. Pathology and Genetics: tumours
of Haematopoietic and Lymphoid Tissues, World Health Organization Classification of Tumors Series . Lyon: IARC Press, 2001.
External links ...
pseudohypoaldosteronism (Type IV renal tubular acidosis )
Diseases of the collecting duct
Type I renal tubular acidosis
of the kidney
Renal cell carcinoma | Wilms' tumor (children)
Diseases of the renal vasculature
renal artery stenosis | vasculitis ...
...n 2004 and it is known as a targeted cancer drug. In addition because of new molecular testing for c-kit, tumors such as GIST GastroIntestinal Stromal tumours
a solid malignancy never associated with blood bourne cancer are also treated with this drug. It works by killing specific cells whereas chemotherapy ...
Tumours in Medical Dictionary
... Tuberous sclerosis or tuberous sclerosis complex (TSC) is a rare, multi-system genetic disease that causes benign tumours
to grow in the brain and on other vital organs such as the kidneys, heart, eyes, lungs, and skin. A... Fact sheet from the National Institute of N...
...leura (pleuritis) and/or accumulation of fluid ... Tumor may be pedunculated and connected to the pleura surface by a fibrous band ... Thirteen tumours
arose from visceral pleura and wedge resection was performed, ... Endometrial deposits in both diaphragm and pleura have a similar appearanc...
...nd treatment options ... Learn about myoma tumours
& treatments: FDA approved focused ultrasound...reatments for myoma ? ... Learn about myoma tumours
and myoma cysts: Pregnancy, menstruation and size. ... Myoma (fibroid) tumours
are usually benign (non-cancerous)...
... infection of the mastoid bone, which is a portion of the temporal bone. ... The mastoid consists of air cells that drain the ... Malignant tumours
of the mastoid are rare, the majority being squamous cell carcinomas. ... The mastoid swelling was hyperaemic, tender and warm. ... Follow...
...eliver bile into the intestine. ... Gall bladder stones are very common in developed countries and most developing ... Sometimes gallbladder tumours
are an incidental finding during surgery for stones. ... Surgery to remove gallbladder cancer can have significant side effects and, ... Ga...
... membranes ... Adenoviruses are a frequent cause of acute upper respiratory tract (URT) ... In 1962, some Adenoviruses were shown to cause tumours
in rodents - this caused ... Adenoviruses cause acute respiratory disease (usually), pneumonia (occasionally) ... The adenoviruses are...
Tumours in Biological News
Scientists closer to making implantable bone material, thanks to new research
...artment of Materials and the Institute of Biomedical Engineering at Imperial College London, says: "Many patients who have had bone removed because of tumours
or accidents live in real pain. By repairing bone defect sites in the body with bone-like material that best mimics the properties of their real bone ...
Breakthrough in radiotherapy promises targeted cancer treatment
...therapy will enable a far more precise and accurate treatment for cancerous tumours
by using real-time images to guide the radiation beam.
Real-time image-g...on oncologists the possibility of instantly modifying the treatment dose as tumours
change in size and shift.
Published in issue 12 of IOP Publishing's Phy...
Stem cell focus for IBD wound healing
...24 molecules on cells to promote even more rapid healing. This may mean less scarring, bowel obstruction and fistulation and less chance of developing tumours
resulting from persistent inflammation. As a result of this, it may also reduce the chance of needing surgery further down the line."
In the early ...
Regulatory molecule for tumor formation or suppression identified by Singapore, US researchers
...ted with zebrafish.
"Interestingly, this microRNA is elevated in many types of human cancers, suggesting that it may contribute to the formation of tumours
by suppressing the p53 protein," said Bing Lim, M.D., Ph.D., lead author and senior group leader at the Genome Institute of Singapore (GIS), a researc...
Researchers discover gene mutations that cause childhood brain cancer
About 250 Canadian children are diagnosed with various types of brain cancer every year. About 70 per cent of these survive. Brain tumours
are the leading cause of childhood cancer deaths. The most common childhood brain cancer is medulloblastoma a tumour that occurs at the back of the b...
Singapore research organisations team up to advance drug discovery using brain tumor stem cells
...ch scientist Dr. Carol Tang, and Dr. Christopher Ang Beng Ti, a NNI neurosurgeon and SICS clinical investigator. The duo have shown that primary brain tumours
are caused by a minority group of cells that display a genetic profile distinct from that of the tumour bulk.
They have reliably established a met...
Brupbacher prize to Nubia Munoz and Sir Richard Peto
...z is being awarded for research into the causes of tumours
such as cervical cancer through human papilloma vi...ndamental epidemiological work on the causation of tumours
through chronic infections, particularly through h...ly a more comparably important, avoidable cause of tumours
in human beings than smoking. Although the fact th...
New research findings may enable earlier diagnosis of uterine cancer
...ases, from arteriosclerosis and dementia to rheumatism, cerebral haemorrhage and cancer. The studies carried out by Sandra Karlsson on human malignant tumours
have confirmed that changes in this gene are present in early as well as late stage cancer.
"This shows that the identified gene has an important rol...
First images from medical beamline at Canadian Light Source
...with the Saskatoon Health Region.
DEI uses the unique properties of synchrotron X-rays to produce images of soft tissues such as muscle, organs and tumours
that do not readily absorb X-rays, making them cloudy or invisible to conventional X-ray radiographs and mammograms. For example, the mouse's lungs ar...
Repairing DNA damage: Researchers discover critical process in cancer treatment
... turned on or off is critical to understanding how tumours
develop. In this system, ATR is the key that turns...etermining if the NER system is working in patient tumours
may therefore be an important first step to chemot...a PhD student at the Universit de Montral.
identified as defective in ATR-mediated repair are...
Tumours in Biological Technology
EMcision Announces 510(k) Clearance of the Habib EndoHPB, its Novel Bipolar RF Device for the Palliation of Biliary and Pancreatic Tumours
EMcision Ltd. today announced clearance for marketing by the United States Food and Drug Administration (K083292) of its Habib™ EndoHPB device for the palliation of biliary and pancreatic tumours.
London (PRWEB) July 14, 2009 -- EMcision Ltd. today announced clear...
Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours
LAUSANNE, Switzerland and TAMPA, Florida, June 18 /PRNewswire/ --
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group
of companies with a focus on the development of prescription drugs that
target unmet medical needs, and Moffitt Cancer Center (Moffitt), a non-profit
Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
CALGARY, Sept. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that following U.S.
Food and Drug Administration (FDA) review, the Company is initiating a U.S.
Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in
Dutch Medical Equipment Producer Nucletron Strengthens Leading Position in Cancer Radiation Therapy Market
...g range of cancer types, including
cancer of the prostate, breast and cervix. The radiation source used for
killing the cancer cells and shrinking the tumours
is placed in or close to
the tumour itself. This precision approach allows doctors to concentrate the
dose of radiation in a smaller area, significant...
Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial
...ination with escalating dosages of REOLYSIN intravenously.
Eligible patients included those who had been diagnosed with advanced or metastatic solid tumours
including pancreatic, lung and ovarian cancers that are refractory (have not responded) to standard therapy or for which no curative standard therapy ...
Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial
...patients with escalating intravenous dosages of REOLYSIN(R). Eligible patients include those who have been diagnosed with advanced or metastatic solid tumours
such as head and neck, melanoma, lung and ovarian that are refractory (have not responded) to standard therapy or for which no curative standard thera...
Oncolytics Biotech(R) Inc. Collaborators Update Combination REOLYSIN(R) and Docetaxel Trial Results at Replicating Oncolytic Virus Meeting
...YSIN(R) in combination with a standard dosage of docetaxel. Eligible patients included those who have been diagnosed with advanced or metastatic solid tumours
that are refractory (have not responded) to standard therapy or for which no curative standard therapy exists.
The poster presentation will be avail...
Oncolytics Biotech Inc. Collaborators Present Positive Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
...nation with a standard
dosage of paclitaxel and carboplatin. Eligible patients include those who
have been diagnosed with advanced or metastatic solid tumours
melanoma, lung and ovarian that are refractory (have not responded) to
standard therapy or for which no curative standard therapy exists.
Oncolytics Biotech Inc. Collaborators Present Positive Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting
...may receive up to eight cycles of treatment in this
Eligible patients include those who have been diagnosed with advanced
or metastatic solid tumours
including bladder, lung, prostate or upper
gastro-intestinal cancers that are refractory (have not responded) to
standard therapy or for which no cura...
Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
...t Frederick (NCI-F)
in the United States. The conference is being held in Geneva, Switzerland,
from October 21-24, 2008.
Mice bearing human melanoma tumours
each received a single injection of
reovirus at various dose levels, administered intravenously. Dose-dependent
tumor growth delay was observed in the...
Tumours in Biological Products
Rabbit Anti-Ki67 Polyclonal Antibody, Unconjugated from GeneTex
Description:...ues the prognostic value is comparable to the tritiated thymidine-labelling index. The correlation between low Ki67 index and histologically low-grade tumours
is strong. Immunogen: Synthetic peptide (unfortunately, the amino acid sequence is considered to be commercially sensitive) (Human)....
Tumours in Biological Definition
... the injections of vectors containing p53 — a gene that suppresses tumours
— directly in to the cancerous tissue, the tumours
stopped growing and were broken down by the body.
Adenoviruses are larger...